Squalene Synthase Inhibitors: Clinical Pharmacology and Cholesterol-Lowering Potential

Author： Charlton-Menys Valentine   Durrington Paul N.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.1, 2007-01, pp. : 11-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Cholesterol-Lowering

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 113-113

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol-Lowering

By  

Current Bioactive Compounds, Vol. 2, Iss. 3, 2006-09 ,pp. : 382-383

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol-Lowering

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 72-72

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol-Lowering

By  

Current Bioactive Compounds, Vol. 1, Iss. 3, 2005-12 ,pp. : 298-298

Bentham Science Publishers

Access to resources Recommend Favorite